Exercise is medicine. Access is the problem.
More than 295,000 people in the UK live with MS or Parkinson's disease. For both conditions, neurologists now regard exercise as critical to symptom management. Yet most patients have no access to condition-specific exercise guidance between clinical appointments. The programmes that could help the most are location-dependent, clinician-rationed, and generic.
"Exercise remains significantly under-prescribed for neurological conditions."
NeuroForward AI delivers personalised, clinically-informed exercise coaching at home, 24/7. The platform adapts to daily symptom fluctuation, medication cycles, and fatigue patterns — designed by specialist physiotherapists and endorsed by consultant neurologists. It's not a fitness app with a medical label. It's a clinical tool built for neurological conditions from the ground up.
"Structured exercise may slow neurodegeneration in Parkinson's disease."
Peer-reviewed research consistently demonstrates that structured, condition-specific exercise changes outcomes for neurological patients. It improves mobility, reduces falls, manages fatigue, and may slow disease progression. Every protocol on our platform is grounded in this evidence base and reviewed by our clinical advisory panel.
"Regular physical activity improves brain processing speed and fatigue in MS."
NeuroForward AI was conceived by a founder living with Parkinson's disease — someone who experienced first-hand the gap between what the evidence demands and what patients actually receive. That lived experience, combined with decades of commercial leadership, drives every decision.
The founding team includes a consultant neurologist from a leading London teaching hospital and a Parkinson's specialist physiotherapist whose clinical methodology forms the core of the platform. This is not built from the outside looking in.
Whether you're a patient, a clinician, a charity, or a potential partner — we'd like to hear from you.
Prefer to email directly? info@neuroforward-ai.co.uk